SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is under pressure as reports of a massive $250 billion AI infrastructure financing deal with OpenAI sparked market concerns over "circular financing" and credit risk. While some investors see this as a strategic move to solidify AI dominance, community discourse is divided between those viewing the pullback as a buying opportunity in a growth leader and others fearing an unsustainable AI bubble.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is facing intense downward pressure driven by market-wide fears over memory cycle peaks and concerns regarding competition from Chinese rivals. Community sentiment is deeply divided, with many long-term investors highlighting strong fundamentals and substantial order backlogs, while others are bracing for further volatility amid heavy institutional shorting and leveraged ETF activity.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is experiencing significant volatility as investors digest conflicting narratives between the company and FDA briefing documents regarding the statistical analysis plans for its DMD candidate. While the FDA has raised concerns about clinical evidence and study design, the community remains deeply divided between those fearing regulatory rejection and those betting on a rebound based on the company's rebuttal and upcoming advisory committee meeting.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility as investors react to mixed semiconductor earnings and ongoing geopolitical tensions in the Middle East. The community remains deeply divided, with some traders attempting to capitalize on short-term price swings while others express concern over the potential for further downside as the sector navigates heavy institutional sell-offs and macro uncertainty.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing intense volatility and bearish pressure as traders debate the sustainability of AI capital expenditures and react to fears of a semiconductor leverage unwind. While the community is deeply divided between those viewing the pullback as a buying opportunity based on strong revenue growth and those fearing further downside, the stock remains a primary focal point for retail investors tracking institutional positioning and technical support levels.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF is experiencing high volatility as investors rotate capital away from crowded AI trades and into broader market sectors, prompting intense debate over whether this represents a healthy consolidation or the start of a deeper cyclical downturn. Market participants are closely watching support levels as semiconductor stocks face pressure from shifting institutional positioning and the ongoing scrutiny of heavy AI infrastructure spending.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is surging following a strong earnings beat and raised 2027 revenue guidance, which has fueled intense community debate over whether the AI infrastructure trade can sustain its momentum. Investors are closely monitoring hyperscaler capital expenditure as the primary catalyst, with many actively discussing whether current price levels represent a value opportunity or an overextended market cycle.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing a sharp selloff as investors react to post-earnings disappointment and fading confidence in key growth projects like Robotaxi and FSD. The community is deeply divided, with bearish traders aggressively scalping short positions amid broken support levels, while vocal bulls remain fixated on the potential for a technical bounce and long-term valuation turnaround.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to the resolution of its arbitration with 3D Medicines, which investors are dissecting for its impact on the company's China licensing strategy and long-term cash position. The community remains heavily polarized, with bulls dismissing the ruling as minor 'noise' while focusing on the imminent Phase 3 REGAL trial catalyst, while bears argue the outcome signals deeper execution risks and potential share price volatility.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is currently experiencing intense retail trading activity driven by extreme volatility in the underlying Tesla stock. Investors are heavily focused on navigating rapid price swings, with community discussions centering on varying strategies like scalping, swing trading, and managing significant unrealized losses while speculating on potential future recovery catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CDP Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.40 up 17.65% YoY
• Reported revenue of $197.39M up 3.94% YoY
• COPT Defense Properties is increasing its full-year 2026 guidance for diluted EPS to a range of $1.39-$1.43 and for diluted FFOPS to a range of $2.76-$2.80 per share, as adjusted.

Stocktwits

COPT Defense Properties

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.40 up 17.65% YoY
• Reported revenue of $197.39M up 3.94% YoY
• COPT Defense Properties is increasing its full-year 2026 guidance for diluted EPS to a range of $1.39-$1.43 and for diluted FFOPS to a range of $2.76-$2.80 per share, as adjusted.

This account has been verified as an official STOCKTWITS representative.